Opening up the advantages of the ruthenocenic bioprobes of ferroquine: distribution and localization in Plasmodium falciparum-infected erythrocytes

The antimalarial ferroquine: from bench to clinic

(2013) C. Biot et al.   Parasite

Pharmacokinetics of Ferroquine, a Novel 4-Aminoquinoline, in Asymptomatic Carriers of Plasmodium falciparum Infections

(2012) Christian Supan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In situ nanochemical imaging of label-free drugs: a case study of antimalarials in Plasmodium falciparum-infected erythrocytes

(2011) Faustine Dubar et al.   CHEMICAL COMMUNICATIONS

Phase I randomized dose-ascending placebo-controlled trials of ferroquine - a candidate anti-malarial drug - in adults with asymptomatic Plasmodium falciparum infection

(2011) Ghyslain Mombo-Ngoma et al.   MALARIA JOURNAL

Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space

(2011) Alexander Alex et al.   MedChemComm

The Antimalarial Ferroquine: Role of the Metal and Intramolecular Hydrogen Bond in Activity and Resistance

(2010) Faustine Dubar et al.   ACS Chemical Biology

The Global Portfolio of New Antimalarial Medicines Under Development

(2009) P Olliaro et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

In Vitro Activity of Ferroquine Is Independent of Polymorphisms in Transport Protein Genes Implicated in Quinoline Resistance in Plasmodium falciparum

(2008) M. Henry et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Structure–activity relationships of 4-N-substituted ferroquine analogues: Time to re-evaluate the mechanism of action of ferroquine

(2008) Christophe Biot et al.   JOURNAL OF ORGANOMETALLIC CHEMISTRY